IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains

Journal of Neuroimmunology

Volumn 96, Issue 1, 1999, Pages 101-111

  Chou, Yuan K ^a,b   Bourdette, Dennis N ^a,b   Barnes, David ^a   Finn, Thomas P ^a,b   Murray, Susan ^a   Unsicker, Laura ^a   Robey, Ian ^a   Whitham, Ruth H ^a,b   Buenafe, Abigail C ^a,b   Allegretta, Mark ^c   Offner, Halina ^a,b   Vandenbark, Arthur A ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Bradley Pharmaceuticals Inc   (United States)

Author keywords

Human T cells; IL 2R; IL 7; Survival factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; MYELIN BASIC PROTEIN; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 7;

ANTIGEN SPECIFICITY; ARTICLE; BLOOD DONOR; CELL TYPE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD11; ANTIGENS, CD19; ANTIGENS, CD56; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; CLONE CELLS; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-7; RECEPTORS, INTERLEUKIN-2; THYMUS GLAND;

EID: 0033119580     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00002-8     Document Type: Article

References (43)

1. Armant M., Delespesse G., Sarfati M. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology. 85:1995;331.
2. Armitage R.J., Namen A.E., Sassenfeld H.M., Grabstein K.H. Regulation of human T cell proliferation by IL-7. J. Immunol. 144:1990;938.
3. Bach F.H., Bach M.L., Sondel P.M. Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature. 259:1976;273.
4. Bourdette D.N., Whitham R.H., Chou Y.K., Morrison W.J., Atherton J., Kenny C., Liefeld D., Hashim G.A., Offner H., Vandenbark A.A. Immunity to TCR peptides in multiple sclerosis: I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol. 152:1994;2510.
5. Boussiotis V.A., Barber D.L., Nakarai T., Freeman G.J., Gribben J.G., Bernstein G.M., D'Andrea A.D., Ritz J., Nadler L.M. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science. 266:1994;1039.
6. Chazen G.D., Pereira G.M.B., LeGros G., Gillis S., Shevach E.M. Interleukin 7 is a T-cell growth factor. Proc. Natl. Acad. Aci. U.S.A. 86:1989;5923-5927.
7. Chou Y.K., Bourdette D.N., Offner H., Whitham R., Wang R., Hashim G.A., Vandenbark A.A. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:1992;105.
8. Chou Y.K., Weinberg A.D., Buenafe A., Bourdette D.N., Whitham R., Kaleeba J.A.R., Robey I.F., Kavanagh D.G., Offner H., Vandenbark A.A. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR Vβ CDR2 peptides: comparison with myelin basic protein-specific T cells. J. Neurosci. Res. 45:1996;838.
9. Conlon D.M., Turner M., Feldman M. Interleukin 7 (murine pre-B cell growth factor/lymphoprotein 1) stimulates thymocyte growth: regulation by transforming growth factor beta. Eur. J. Immunol. 19:1989;783.
10. DeFreitas E.C., Sandberg-Wollheim M., Schonely K., Boufal M., Koprowski H. Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients. Proc. Natl. Acad. Sci. U.S.A. 83:1986;2637.
11. Diebler G.E., Boyd L.F., Kies M.W. Enzymatic and nonenzymatic degradation of myelin basic protein. Neurochemistry. 9:1984;1371.
12. Grabstein K.H., Namen A.E., Shanebeck K., Voice R.F., Reed S.G., Widmer M.B. Regulation of T cell proliferation by IL-7. J. Immunol. 144:1990;3015.
13. Hashim G.A., Day E.D., Fredane L., Intintola P., Carvalho E. Biological activity of region 65 to 102 of the myelin basic protein. J. Neurosci. Res. 16:1986;467.
14. Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Taniguchi T. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science. 244:1989;551.
15. Lee S.H., Fujita N., Mashima T., Tsuruo T. Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the cpp32-like protease activation and inducing the bcl-2 expression. Oncogene. 13:1996;2131.
16. Leong K.H., Ramshaw I.A., Ramsey A.J. Interleukin-7 enhances cell-mediated immune responses in vivo in an IL-2 dependent manner. Viral Immunol. 10:1997;1.
17. Lynch D.H., Miller R.E. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med. 179:1994;31-42.
18. Mehrotra P.T., Grant A.J., Siegel J.P. Synergistic effects of IL-7 and IL-12 on human T cell activation. J. Immunol. 154:1995;5093.
19. Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z.J., Oishi I., Silvennoinen O., Witthuhn B.A., Ihle J.N., Taniguchi T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science. 266:1994;1045.
20. Muegge K., Vila M.P., Durum S.K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor β gene. Science. 261:1993;93.
21. Namen A.E., Schmierer A.E., March C.J., Overrell R.W., Park L.S., Urdal D.L., Mochizuki D.Y. B cell precursor growth-promoting activity. Purification and characterization of a growth factor activity on lymphocyte precursors. J. Exp. Med. 167:1988;988.
22. Noguchi M., Nakamura Y., Russell S.M., Ziegler S.F., Tsang M., Cao X., Leonard W.J. Interleukin-2 receptor chain: a functional component of the Interleukin-7 receptor. Science. 262:1993;1877.
23. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:1973;749.
24. Okazaki H., Ito M., Sudo T., Hattori M., Kano S., Katsura Y., Minato N. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing αβ or τδ T-cell receptors in vitro: synergism with IL-2. J. Immunol. 143:1989;2917.
25. Olsson T., Wang W.Z., Hojeberg B.et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ J. Clin. Invest. 86:1990;981.
26. Park L.S., Friend D.J., Schmierer A.E., Dower S.K., Namen A.E. Murine Interleukin-7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J. Exp. Med. 171:1990;1073.
27. Rich B.E. Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice. Immunol. 92:1997;374.
28. Russell S.M., Johnston J.A., Noguchi M., Kawamura M., Bacon C.M., Friedmann M., Berg M., McVicar D.W., Witthuhn B.A., Silvennoinen O., Goldman A.S., Schmalstieg F.C., Ihle J.N., O'Shea J.J., Leonard W.J. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science. 266:1994;1042.
29. Sun J.B., Olsson T., Wang W.Z.et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1991;1461.
30. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the γ chain of the human IL-2 receptor. Science. 257:1992;379.
31. Tamura T., Nakano H., Nagase H., Morokata T., Igarashi O., Oshimi Y., Miyazaki S., Nariuchi H. Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. J. Immunol. 155:1995;4692.
32. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 73:1993;5. (Minireview).
33. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: I. Data analysis. J. Immunol. 26:1981;1614.
34. Ting C.C., Wang J., Yang Y. Interleukin-2 and Interleukin-7 augment the cytolytic activity and expand the antitumor killing spectrum of alpha CD3-induced activated killer cells: potential use in the immunotherapy on non-immunogenic tumors. Cancer Immunol. Immunotherapy. 43:1996;283.
35. Tushinski R.J., McAlister I.B., Williams D.E., Namen A.E. The effects of Interleukin 7 (IL-7) on human bone marrow in vitro. Exp. Hematol. 19:1991;749.
36. Van Parijs L., Ibraghimov A., Abbas A.K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:1996;321.
37. Van Noort J.M., El Ouagmiri M., Boon J., Van Sechel A.C. Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography. J. Chromatogr. (Biomedical Applications). 653:1994;155.
38. Vandenbark A.A., Bourdette D.N., Whitham R., Chou Y.K., Hashim G., Offner H. Episodic changes in T-cell frequencies to myelin basic protein in patients with multiple sclerosis. Neurology. 43:1993;2416.
39. Varas A., Vicente A., Jimenez E., Alonso L., Moreno J., Munoz J.J., Zapata A.G. Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor αβ cells selectively to the CD8+ cell lineage. Immunology. 92:1997;457.
40. Vella A.T., Dow S., Potter T.A., Kappler J., Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad Sci. U.S.A. 95:1998;3810.
41. Vella A., Teague T.K., Ihle J., Kappler J., Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:1997;325.
42. Watson J.D., Morrissey P.J., Namen A.E., Conlon P.J., Widmer M.B. Effect of IL-7 on the growth of fetal thymocytes in culture. J. Immunol. 143:1989;1215.
43. Zhang J.W., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D. Increased frequency of interleukin-2-responsive T cells specific for myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973.